← Back to Patent Explorer
US4112224A Expired / Lapsed US ⏱️ 0.0 years remaining

Biheterocyclic-9,11-trideoxy-PGF compounds

Assignee: Pharmacia and Upjohn Co
•
Filing: 1977-06-30
•
Granted: 1978-09-05
•
Expires: 1997-06-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present specification; provides bicyclic nitrogen-containing 9,11,15-trideoxy-prostaglandin F analogs which are useful anti-inflammatory agents, anti-asthma agents, and platelet aggregation inhibitors, and a process for their preparation. Included are compounds of the following structural formulas: ##STR1## Especially described in the present specification are 9,11-trideoxy-9α,11α-azo-PGF-type; 9,11,15-trideoxy-11α,9α-epoxyimino-PGF-type; 9,11,15-trideoxy-9α,11α-epoxyimino-PGF-type; N,N'-dialkyl-9,11,15-trideoxy-9α11α-hydrazino-PGF-type; N,N'-bis(alkylcarbonyl)-9,11,15-trideoxy-9α,11α-hydrazino-PGF-type; N-alkyl-9,11,15-trideoxy-11α,9α-epoxyimino-PGF-type; N-(alkylcarbonyl)-9,11,15-trideoxy-11α,9α-epoxyimino-PGF-type; N-alkyl-9,11,15-trideoxy-9α,11α-epoxyimino-PGF-type; N-(alkylcarbonyl)-9,11,15-trideoxy-9α,11α-epoxyimino-PGF-type; 9,11,15-trideoxy-9α,11α-alkylhydrazino-PGF-type; 9,11,15-trideoxy-9α,11-α-(alkylcarbonyl)hydrazino-PGF-type; 9,11,15-trideoxy-11α,9α-alkylhydrazino-PGF-type; and 9,11,15-trideoxy-11α,9α-(alkylcarbonyl)-hydrazino-PGF-type compounds.

Inventors

  • 👤 Gordon L. Bundy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 14:30
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/93; C07D307/935; C07C; C07C405/00; C07C405/0008; C07C405/0016; C07C405/0041; C07D209/00; C07D209/02; C07D209/44; C07D209/48; C07D231/00; C07D231/54; C07D261/00; C07D261/02; C07D261/04; C07D261/20

Claims Analysis

Total Claims: 53
Claim 1
Independent Claim 817 words
A prostaglandin analog of the formula ##STR57## wherein W 1 is ##STR58## wherein R 2 is alkyl of one to 4 carbon atoms, inclusive or alkylcarbonyl of one to 4 carbon atoms, inclusive; wherein Y 1 is (1) trans--CH═CH--CH 2 --, (2) --(ch 2 ) 3 -, (3) --c|c--ch 2 --, (4) trans---CH 2 --CH═CH--,or (5) cis--CH═CH--CH 2 -- wherein L 1 is ##STR59## or a mixture of ##STR60## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the provisio that one of R 3 and R 4 is fluoro only when the other is hydrogen or fluoro; wherein Z 1 is (1) cis--CH═CH--CH 2 --(CH 2 ) g --CH 2 --, (2) cis--CH═CH--CH 2 --(CH 2 ) g --CF 2 , (3) cis--CH 2 --CH═CH--(CH 2 ) g --CH 2 --, (4) --(ch 2 ) 3 --(ch 2 ) g --CH 2 --, (5) --(ch 2 ) 3 --(ch 2 ) g --CF 2 --, (6) --ch 2 --o--ch 2 --(ch 2 ) g --CH 2 --, ##STR61## wherein g is one, 2, or 3; wherein R 7 is (1) --(CH 2 ) m --CH 3 , ##STR62## wherein h is zero to 3, inclusive, wherein m is one to 5, inclusive, T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive and s is zero, one, 2, or 3, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl, with the further proviso that R 7 is ##STR63## wherein T and s are as defined above, only when R 3 and R 4 are hydrogen or methyl, being the same or different; wherein X 1 is (1) --COOR 1 wherein R 1 is hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive; phenyl; phenyl substituted with one, two, or three chloro or alkyl of one to 3 carbon atoms; phenyl substituted in the para position by ##STR64## wherein R 25 is methyl, phenyl, acetamidophenyl, benzamidophenyl, or --NH 2 ; R 26 is methyl, phenyl, --NH 2 , or methoxy; and R 27 is hydrogen or acetamido; inclusive, or a pharmacologically acceptable cation; (2) --CH 2 OH; (3) --col 4 , wherein L 4 is (a) amido of the formula --NR 21 R 22 , wherein R 21 and R 22 are hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl; phenyl substituted with one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; hydroxy, carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive, or nitro; carboxyalkyl of one to four carbon atoms, inclusive; carbamoylalkyl of one to four carbon atoms, inclusive; cyanoalkyl of one to four carbon atoms, inclusive, acetylalkyl of one to four carbon atoms, inclusive; benzoylalkyl of one to four carbon atoms, inclusive; benzoylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; hydroxy, alkoxy of one to 3 carbon atoms, inclusive; carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive; or nitro; pyridyl; pyridyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; or alkoxy of one to 3 carbon atoms, inclusive; pyridylalkyl of one to 4 carbon atoms, inclusive; pyridylalkyl of one to 4 carbon atoms, inclusive; pyridylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; hydroxy, alkoxy of one to 3 carbon atoms, inclusive; hydroxyalkyl of one to 4 carbon atoms, inclusive; dihydroxyalkyl of one to 4 carbon atoms, and trihydroxyalkyl of one to 4 carbon atoms; with the further proviso that not more than one of R 21 and R 22 is other than hydrogen or alkyl; (b) cycloamido selected from the group consistng of ##STR65## wherein R 21 and R 22 are as defined above; (c) carbonylamido of the formula --NR 23 COR 21 , wherein R 23 is hydrogen or alkyl of one to 4 carbon atoms and R 21 is as defined above; (d) sulphonylamido of the formula --NR 23 SO 2 R 21 , wherein R 21 and R 23 are as defined above; or (e) hydrazino of the formula --NR 23 R 24 , wherein R 24 is amido of the formula --NR 21 R 22 , as defined above, or cycloamido, as defined above; or (4) --CH 2 NL 2 L 3 , wherein L 2 and L 3 are hydrogen or alkyl of one to 4 carbon atoms, inclusive, being the same or different; or the pharmacologically acceptable acid addition salts thereof when X 1 is not --COOR 1 and R 1 a pharmacologically acceptable cation.
Claim 2
Dependent Claim 817 words
A prostaglandin analog of the formula ##STR57## wherein W 1 is ##STR58## wherein R 2 is alkyl of one to 4 carbon atoms, inclusive or alkylcarbonyl of one to 4 carbon atoms, inclusive; wherein Y 1 is (1) trans--CH═CH--CH 2 --, (2) --(ch 2 ) 3 -, (3) --c|c--ch 2 --, (4) trans---CH 2 --CH═CH--,or (5) cis--CH═CH--CH 2 -- wherein L 1 is ##STR59## or a mixture of ##STR60## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the provisio that one of R 3 and R 4 is fluoro only when the other is hydrogen or fluoro; wherein Z 1 is (1) cis--CH═CH--CH 2 --(CH 2 ) g --CH 2 --, (2) cis--CH═CH--CH 2 --(CH 2 ) g --CF 2 , (3) cis--CH 2 --CH═CH--(CH 2 ) g --CH 2 --, (4) --(ch 2 ) 3 --(ch 2 ) g --CH 2 --, (5) --(ch 2 ) 3 --(ch 2 ) g --CF 2 --, (6) --ch 2 --o--ch 2 --(ch 2 ) g --CH 2 --, ##STR61## wherein g is one, 2, or 3; wherein R 7 is (1) --(CH 2 ) m --CH 3 , ##STR62## wherein h is zero to 3, inclusive, wherein m is one to 5, inclusive, T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive and s is zero, one, 2, or 3, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl, with the further proviso that R 7 is ##STR63## wherein T and s are as defined above, only when R 3 and R 4 are hydrogen or methyl, being the same or different; wherein X 1 is (1) --COOR 1 wherein R 1 is hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive; phenyl; phenyl substituted with one, two, or three chloro or alkyl of one to 3 carbon atoms; phenyl substituted in the para position by ##STR64## wherein R 25 is methyl, phenyl, acetamidophenyl, benzamidophenyl, or --NH 2 ; R 26 is methyl, phenyl, --NH 2 , or methoxy; and R 27 is hydrogen or acetamido; inclusive, or a pharmacologically acceptable cation; (2) --CH 2 OH; (3) --col 4 , wherein L 4 is (a) amido of the formula --NR 21 R 22 , wherein R 21 and R 22 are hydrogen; alkyl of one to 12 carbon atoms, inclusive; cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl; phenyl substituted with one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; hydroxy, carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive, or nitro; carboxyalkyl of one to four carbon atoms, inclusive; carbamoylalkyl of one to four carbon atoms, inclusive; cyanoalkyl of one to four carbon atoms, inclusive, acetylalkyl of one to four carbon atoms, inclusive; benzoylalkyl of one to four carbon atoms, inclusive; benzoylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; hydroxy, alkoxy of one to 3 carbon atoms, inclusive; carboxy, alkoxycarbonyl of one to 4 carbon atoms, inclusive; or nitro; pyridyl; pyridyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; or alkoxy of one to 3 carbon atoms, inclusive; pyridylalkyl of one to 4 carbon atoms, inclusive; pyridylalkyl of one to 4 carbon atoms, inclusive; pyridylalkyl substituted by one, 2, or 3 chloro, alkyl of one to 3 carbon atoms, inclusive; hydroxy, alkoxy of one to 3 carbon atoms, inclusive; hydroxyalkyl of one to 4 carbon atoms, inclusive; dihydroxyalkyl of one to 4 carbon atoms, and trihydroxyalkyl of one to 4 carbon atoms; with the further proviso that not more than one of R 21 and R 22 is other than hydrogen or alkyl; (b) cycloamido selected from the group consistng of ##STR65## wherein R 21 and R 22 are as defined above; (c) carbonylamido of the formula --NR 23 COR 21 , wherein R 23 is hydrogen or alkyl of one to 4 carbon atoms and R 21 is as defined above; (d) sulphonylamido of the formula --NR 23 SO 2 R 21 , wherein R 21 and R 23 are as defined above; or (e) hydrazino of the formula --NR 23 R 24 , wherein R 24 is amido of the formula --NR 21 R 22 , as defined above, or cycloamido, as defined above; or (4) --CH 2 NL 2 L 3 , wherein L 2 and L 3 are hydrogen or alkyl of one to 4 carbon atoms, inclusive, being the same or different; or the pharmacologically acceptable acid addition salts thereof when X 1 is not --COOR 1 and R 1 a pharmacologically acceptable cation.
Claim 3
Dependent Claim 12 words
A prostaglandin analog according to claim 1, wherein W 1 is ##STR66##
Claim 4
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-epoxyimino-prostaglandin F 2 , a prostaglandin analog according to claim 2.
Claim 5
Dependent Claim 15 words
Cis-4,5-Didehydro-9,11,15-trideoxy-9α,11α- or 11α,9α-epoxyimino-prostaglandin F 1 , methyl ester, a prostaglandin analog according to claim 2.
Claim 6
Dependent Claim 11 words
9,11,15-Trideoxy-11α,9α-epoxyimino-prostaglandin F 2 , a prostaglandin analog according to claim 2.
Claim 7
Dependent Claim 12 words
A prostaglandin analog according to claim 1, wherein W 1 is ##STR67##
Claim 8
Dependent Claim 14 words
A prostaglandin analog according to claim 2, wherein X 1 is --COOR 1 .
Claim 9
Dependent Claim 14 words
A prostaglandin analog according to claim 7, wherein Y 1 is trans-CH 2 --CH═CH--.
Claim 10
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-13,14-dihydro-trans-14,15-didehydro-prostaglandin F 2 , a prostaglandin analog according to claim 8.
Claim 11
Dependent Claim 14 words
A prostaglandin analog according to claim 7, wherein T 1 is cis--CH═CH--CH 2 --.
Claim 12
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-cis-13-prostaglandin F 2 , a prostaglandin analog according to claim 10.
Claim 13
Dependent Claim 14 words
A prostaglandin analog according to claim 7, wherein Y 1 is --C.tbd.C--CH 2 --.
Claim 14
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-13,14-didehydro-prostaglandin F 2 , a prostaglandin analog according to claim 12.
Claim 15
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-13,14-didehydro-prostaglandin F 1 , a prostaglandin analog according to claim 12.
Claim 16
Dependent Claim 16 words
A prostaglandin analog according to claim 7, wherein Y 1 is --(CH 2 ) 3 --.
Claim 17
Dependent Claim 12 words
9,11,15-Trideoxy-9α, 11α-azo-13,14-dihydro-prostaglandin F 2 , a prostaglandin analog according to claim 15.
Claim 18
Dependent Claim 13 words
9,11,15-Trideoxy-9α,11α-azo-13,14-dihydro-prostaglandin F 2 , methyl ester, a prostaglandin analog according to claim 15.
Claim 19
Dependent Claim 14 words
A prostaglandin analog according to claim 7, wherein Y 1 is trans--CH═CH--CH 2 --.
Claim 20
Dependent Claim 20 words
A prostaglandin analog according to claim 18, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ) g --CF 2 --.
Claim 21
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-2,2-difluoro-prostaglandin F 2 , a prostaglandin analog according to claim 19.
Claim 22
Dependent Claim 20 words
A prostaglandin analog according to claim 18, wherein Z 1 is cis--CH 2 --CH═CH--(CH 2 ) g --CH 2 --.
Claim 23
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-cis-4,5-didehydro-prostaglandin F 2 , a prostaglandin analog according to claim 21.
Claim 24
Dependent Claim 22 words
A prostaglandin analog according to claim 18, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ) g --CH 2 --.
Claim 25
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-prostaglandin F 1 , a prostaglandin analog according to claim 23.
Claim 26
Dependent Claim 22 words
A prostaglandin analog according to claim 18, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ) g --CF 2 --.
Claim 27
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-2,2-difluoro-prostaglandin F 1 , a prostaglandin analog according to claim 25.
Claim 28
Dependent Claim 22 words
A prostaglandin analog according to claim 18, wherein Z 1 is --CH 2 --O--CH 2 --(CH 2 ) g --CH 2 --.
Claim 29
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-5-oxa-prostaglandin F 1 , a prostaglandin analog according to claim 27.
Claim 30
Dependent Claim 12 words
A prostaglandin analog according to claim 18, wherein Z 1 is ##STR68##
Claim 31
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-3,7-inter-m-phenylene-4,5,6-trinor-prostaglandin F 1 , a prostaglandin analog according to claim 29.
Claim 32
Dependent Claim 12 words
A prostaglandin analog according to claim 18, wherein Z 1 is ##STR69##
Claim 33
Dependent Claim 12 words
9,11,15-Trideoxy-9α,11α-azo-3,7-inter-m-phenylene-3-oxa-4,5,6-trinor-prostaglandin F 1 , a prostaglandin in analog according to claim 31.
Claim 34
Dependent Claim 20 words
A prostaglandin analog according to claim 18, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ) g --CH 2 --.
Claim 35
Dependent Claim 12 words
A prostaglandin analog according to claim 33, wherein R 7 is ##STR70##
Claim 36
Dependent Claim 11 words
9.11,15-Trideoxy-9α,11α-axo-16-phenoxy-17,18,19,20-tetranor-prostaglandin F 2 , a prostaglandin analog according to claim 34.
Claim 37
Dependent Claim 12 words
A prostaglandin analog according to claim 33, wherein R 7 is ##STR71##
Claim 38
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-17-phenyl-18,19,20-trinor-prostaglandin F 2 , a prostaglandin analog according to claim 36.
Claim 39
Dependent Claim 18 words
A prostaglandin analog according to claim 33, wherein R 7 is --(CH 2 ) m --CH 3 .
Claim 40
Dependent Claim 11 words
A prostaglandin analog according to claim 38, wherein g is 3.
Claim 41
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-2a,2b-dihomo-prostaglandin F 2 , a prostaglandin analog according to claim 39.
Claim 42
Dependent Claim 11 words
A prostaglandin analog according to claim 38, wherein g is one.
Claim 43
Dependent Claim 19 words
A prostaglandin analog according to claim 41, wherein at least one of R 3 and R 4 is methyl.
Claim 44
Dependent Claim 16 words
A prostaglandin analog according to claim 42, wherein R 3 and R 4 are both methyl.
Claim 45
Dependent Claim 13 words
9.11,15-Trideoxy-9α,11α-azo-16,16-dimethyl-prostaglandin F 2 , methyl ester, a prostaglandin analog according to claim 43.
Claim 46
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-16,16-dimethyl-prostaglandin F 2 , a prostaglandin analog according to claim 43.
Claim 47
Dependent Claim 19 words
A prostaglandin analog according to claim 41, wherein at least one of R 3 and R 4 is fluoro.
Claim 48
Dependent Claim 16 words
A prostaglandin analog according to claim 46, wherein R 3 and R 4 are both fluoro.
Claim 49
Dependent Claim 13 words
9,11,15-Trideoxy-9α,11α-azo-16,16-difluoro-prostaglandin F 2 , methyl ester, a prostaglandin analog according to claim 47.
Claim 50
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-16,16-difluoro-prostaglandin F 2 , a prostaglandin analog according to claim 47.
Claim 51
Dependent Claim 16 words
A prostaglandin analog according to claim 41, wherein R 3 and R 4 are both hydrogen.
Claim 52
Dependent Claim 13 words
9,11,15-Trideoxy-9α,11α-azo-prostaglandin F 2 , methyl ester, a prostaglandin analog according to claim 50.
Claim 53
Dependent Claim 11 words
9,11,15-Trideoxy-9α,11α-azo-prostaglandin F 2 , a prostaglandin analog according to claim 50.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-09-04 1982-03-06 1982-09-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-09-04 1986-03-06 1986-09-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-09-04 1990-03-06 1990-09-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag